CAS No. 108-88-3
Toluene (methylbenzene) is a flammable, liquid, aromatic hydrocarbon. It is a high production chemical isolated from crude oil. Toluene is used widely as a solvent and to synthesize chemicals such as benzene, trinitrotoluene, and toluene diisocyanate. As with other aromatic solvents, it is a minor component of gasoline, and additives containing toluene are used as octane boosters. Toluene is detected frequently in urban air, especially in high motor traffic areas and near industrial areas or hazardous waste sites (ATSDR, 2000; Mukund et al., 1996). Indoor air levels of toluene can exceed outdoor levels, largely due to consumer products (e.g., nail polish solvent, adhesive glues, paints, and paint thinner) and cigarette smoke (ATSDR, 2000; Gordon et al., 1999). Toluene does not persist in soil due to its volatility and is not detected commonly in U.S. groundwater and drinking water supplies (USGS, 2006).
The general population is exposed to toluene mainly by breathing contaminated air. Workplace exposure to toluene may occur during the production and use of petrochemicals and solvents. Toluene is well absorbed by inhalation, dermal, and oral exposure routes. After absorption, toluene is metabolized rapidly by hepatic microsomal enzymes, and the major urinary excretion product is hippuric acid. Other urinary metabolites include ortho- and para-cresol, S-benzylmercapturic acid, and S-para-toluylmercapturic acid.
Human health effects from toluene at low environmental doses or at biomonitored levels from low environmental exposures are unknown. Humans exposed to high levels of toluene in air for a short time can show central nervous system depression (lassitude, stupor, and coma). Persons with short term exposures to toluene at levels higher than workplace air standards have shown poor performance on cognitive tests, neurobehavioral impairment, and eye and upper respiratory tract irritation (ATSDR, 2000). Its distinctive aromatic smell is detectable well below workplace air standards. Chronic solvent inhalant abuse, usually involving toluene and other volatile hydrocarbons, has resulted in permanent brain damage with dementia (Filley et al., 2004). Chronic occupational exposures at levels exceeding workplace standards have damaged hearing and possibly color vision (Lomax et al., 2004). In animal studies, prenatal toluene exposure impaired fetal growth and skeletal development, and altered behavioral development in the offspring (ADSDR, 2000; Jones and Balster, 1997). Evidence for human reproductive effects is inconclusive, and reports of developmental effects have been reported mainly in children exposed in utero by maternal solvent abuse (Bukowski, 2001). Epidemiologic studies of workers exposed to toluene (or toluene together with other solvents) have not demonstrated increased risks for cancer, and animal studies have not demonstrated an increased incidence of tumors (IARC, 1999). IARC determined that toluene was not classifiable with regard to human carcinogenicity. The U.S. EPA has established a drinking water and other environmental standards for toluene. The FDA has established a bottle water standard and level for toluene as an indirect food additive. OSHA and ACGIH established workplace standards and guidelines, respectively, for toluene. Information about external exposure (i.e., environmental levels) and health effects is available from ATSDR at: http://www.atsdr.cdc.gov/toxprofiles/.
Levels of blood toluene reflect recent exposure. A nonrepresentative sample of adults in NHANES III (1988–1994) had geometric mean and median blood toluene levels, respectively, of 0.52 and 0.28 µg/L (Ashley et al., 1994; Churchill et al., 2001), generally higher than comparable levels in NHANES 2001–2002 and 2003–2004. Similar median blood toluene levels have been reported in U.S. children (Sexton et al., 2005, 2006) and in studies of adults without occupational exposure (Backer et al., 1997; Bonanno et al., 2001; Buckley et al., 1997). Population studies in Italy and Mexico have reported median blood toluene levels that were about twice as high as those in the U.S. (Brugnone et al., 1994; Carrer et al., 2000; Lemire et al., 2004; Perbellini et al., 2002). Geometric mean blood toluene levels were 0.191 and 0.669 ng/mL in non-smoking and smoking adults, respectively, from a subsample of NHANES 1999–2000 participants (Lin et al., 2008). Other studies have reported blood toluene levels that were approximately four times higher in smokers than non-smokers (Ashley et al., 1995; Bonanno et al., 2001; Brugnone et al., 1994; Perbellini et al., 2002), but environmental tobacco smoke exposure has not been associated with elevated blood toluene levels (Carrer et al., 2000; Sexton et al., 2005). Exposure to gasoline fumes can increase blood toluene levels during self-service refueling (Backer et al., 1997). Vehicle exhaust and gasoline fumes in such occupational settings as gas stations, automobile repair shops, and street vending can result in blood toluene levels that are two to three times higher than background levels (Mannino et al., 1995; Romieu et al., 1999).
Finding a measureable amount of toluene in blood does not mean that the level of toluene causes an adverse health effect. Biomonitoring studies of blood toluene can provide physicians and public health officials with reference values so that they can determine whether or not people have been exposed to higher levels of toluene than levels found in the general population. Biomonitoring data can also help scientists plan and conduct research on exposure and health effects.
Effects of long term exposure
Serious adverse behavioural effects are often associated with toluene abuse related to the deliberate inhalation of solvents. Long term toluene exposure is often associated with effects such as: psychoorganic syndrome; visual evoked potential (VEP) abnormality; toxic polyneuropathy, cerebellar, cognitive, and pyramidal dysfunctions; optic atrophy; and brain lesions.
The neurotoxic effects of long term use (in particular repeated withdrawals) of toluene may cause postural tremors by upregulating GABA receptors within the cerebellar cortex. Treatment withGABA agonists such as, benzodiazepines provide some relief from toluene induced tremor and ataxia. An alternative to drug treatment is vim thalamotomy. The tremors associated with toluene misuse do not seem to be a transient symptom, but an irreversible and progressive symptom which continues after solvent abuse has been discontinued.
There is some evidence that low level toluene exposure may cause disruption in the differentiation of astrocyte precursor cells. This does not appear to be a major hazard to adults; however, exposure of pregnant women to toluene during critical stages of fetal development could cause serious disruption to neuronal development.
Toluene in commonly found in oil and gas development all throughout Colorado. Hundreds of cases of oil and gas spill/incidents that have occurred in Colorado report toluene as one of the top chemicals that has been found to exceed acceptable levels in many soil and water samples. In some reported spill cases, hundreds, or even thousands of gallons of ‘liquid industrial waste’ that contained toluene were never recovered from the soil or water where the spill occurred. It’s most often the case that the spill was not discovered for months due to lack of adequate manpower via the COGCC . This appears to be a failure by the State of Colorado to prevent and mitigate adverse environmental and human health impacts. One such case of the industry contaminating the Laramie-Hills Aquifer with toluene can be found HERE
Toluene is a very harmful chemical to children and pregnant mothers. Please understand that toluene is a widely used chemical by the oil and gas industry, and if you have active oil and gas wells in close proximity to your home, you must address the presence of this dangerous chemical as a valid concern.